
Telum Therapeutics Announces Grant of European Patent EP4118192A1 for NewRecombinant Lysin to Treat Gram-Negative Bacterial Infections
Pamplona, Spain – March 11, 2021 – Telum Therapeutics, a leading biotechnology company specializing in drug discovery, is pleased to announce the grant of European Patent EP4118192A1, titled “New
